Applied Dna Sciences Inc (NASDAQ:BNBX) Short Interest Down 50.0% in May

Applied Dna Sciences Inc (NASDAQ:BNBX) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totaling 116,017 shares, a drop of 50.0% from the April 30th total of 231,818 shares. Based on an average trading volume of 58,204 shares, the short-interest ratio is currently 2.0 days. Currently, 1.7% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Applied Dna Sciences in a report on Friday, April 24th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Applied Dna Sciences Stock Up 25.6%

Applied Dna Sciences stock traded up $0.11 during mid-day trading on Monday, hitting $0.54. The company’s stock had a trading volume of 844,281 shares, compared to its average volume of 604,651. The firm has a market capitalization of $3.89 million, a PE ratio of -0.01 and a beta of 0.52. Applied Dna Sciences has a twelve month low of $0.35 and a twelve month high of $7.15. The firm’s fifty day simple moving average is $0.55.

Applied Dna Sciences (NASDAQ:BNBX) last posted its quarterly earnings results on Friday, May 15th. The company reported ($0.68) earnings per share (EPS) for the quarter. Applied Dna Sciences had a negative return on equity of 349.95% and a negative net margin of 1,647.25%.The business had revenue of $1.02 million during the quarter.

About Applied Dna Sciences

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.